Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04163952
Title Talimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Skin
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Rutgers, The State University of New Jersey

skin squamous cell carcinoma


Panitumumab + Talimogene laherparepvec

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.